Crossmark

Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection

Published Online: 2021-10-29

Published Print: 2021-12

Authors

Hamzeh-Cognasse, Hind

Mansour, Alexandre

Reizine, Florian

Mismetti, Patrick

Gouin-Thibault, Isabelle

Cognasse, Fabrice https://orcid.org/0000-0001-8041-928X
Funding

Funding for this research was provided by:

etablissement français du sang

université de rennes 1 (CFTR2 - COVID Fast Track Research Rennes, CFTR2 - COVID Fast Track Research Rennes)
License Information

Text and Data Mining valid from 2021-10-29

Version of Record valid from 2021-10-29
More Information

Article History

Received: 30 July 2021

Accepted: 14 October 2021

First Online: 29 October 2021

Declarations

:

: This study was approved by the local ethics committee (2020-A01100-39) with respect to the Declaration of Helsinki. Written informed consent was obtained from all the patients or their trusted persons. Data collection from the PLASMACOV cohort was approved by the French national ethics committee (2020-A00728-31).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current